Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study.

Jean-Louis Montastruc Alessandra Bura Rivière

Published in: European journal of clinical pharmacology (2023)

The present study suggests an increased risk of "serious" bleeding when SRIs (but not NSMRIs) are associated with antithrombotics (all antithrombotics and not only DOACs).

Keyphrases

atrial fibrillation
major depressive disorder
bipolar disorder
venous thromboembolism
direct oral anticoagulants